<?xml version="1.0" encoding="UTF-8"?>
<ref id="B95-vaccines-07-00053">
 <label>95.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rossignol</surname>
    <given-names>J.F.</given-names>
   </name>
  </person-group>
  <article-title>Nitazoxanide: A first-in-class broad-spectrum antiviral agent</article-title>
  <source>Antiviral Res.</source>
  <year>2014</year>
  <volume>110</volume>
  <fpage>94</fpage>
  <lpage>103</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2014.07.014</pub-id>
  <?supplied-pmid 25108173?>
  <pub-id pub-id-type="pmid">25108173</pub-id>
 </element-citation>
</ref>
